A phase II study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma (Q33328088)

25 July 2017

title

A phase II study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma (English)

1 reference

ORCID Public Data File 2021

25 July 2017

1 reference

1 reference

1 reference

author name string

Yeo W

1

1 reference

25 July 2017

Leung TW

2

1 reference

25 July 2017

Chan AT

3

1 reference

25 July 2017

Chiu SK

4

1 reference

25 July 2017

Yu P

5

1 reference

25 July 2017

Mok TS

6

1 reference

25 July 2017

Johnson PJ

7

1 reference

25 July 2017

language of work or name

1 reference

1 December 1998

1 reference

European Journal of Cancer

25 July 2017

published in

1 reference

25 July 2017

volume

34

1 reference

25 July 2017

issue

13

1 reference

25 July 2017

page(s)

2027-2031

1 reference

Distant metastases of nasopharyngeal carcinoma: a study of 256 male patients

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900280-9

7 January 2021

Chemotherapy for recurrent or metastatic carcinoma of the nasopharynx. A review of the Princess Margaret Hospital experience

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900280-9

7 January 2021

Chemotherapy for nasopharyngeal carcinoma. A ten-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900280-9

7 January 2021

Phase II study of the combination of carboplatin and 5-fluorouracil in metastatic nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900280-9

7 January 2021

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900280-9

7 January 2021

Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900280-9

7 January 2021

Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900280-9

7 January 2021

A proposed modification of the Ho stage-classification for nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900280-9

7 January 2021

Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900280-9

7 January 2021

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900280-9

7 January 2021

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900280-9

7 January 2021

10.1016/S0959-8049(98)00280-9

Identifiers

DOI

1 reference

25 July 2017

1 reference